Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: May 30, 2023

Wockhardt Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for WOCKHARDT, and what generic and branded alternatives to WOCKHARDT drugs are available?

WOCKHARDT has one hundred and thirty-five approved drugs.

There are three tentative approvals on WOCKHARDT drugs.

Drugs and US Patents for Wockhardt

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-003 May 11, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Wockhardt Bio Ag VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090216-002 May 24, 2010 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Wockhardt Bio Ag HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride SYRUP;ORAL 087294-001 Apr 12, 1982 AA RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Wockhardt FUROSEMIDE furosemide INJECTABLE;INJECTION 077941-001 Mar 22, 2007 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Wockhardt Bio Ag HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 088008-001 Mar 3, 1983 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Wockhardt Ltd CARBIDOPA, LEVODOPA AND ENTACAPONE carbidopa; entacapone; levodopa TABLET;ORAL 090833-005 Nov 20, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.